Taken together, IL-27 has important implications in the development of an anti-tumor T cell response by enhancing CTL activation, promoting Th1 mediated anti-tumor immune responses, and inhibiting Th2 and Treg mediated immune suppression. Here, IL27 is linked to neoplasm.